Glenmark Pharmaceuticals Limited informed the stock exchanges that Glenmark Pharmaceuticals Inc., USA, announced the launch of Clindamycin Phosphate Foam, 1%. On February 12, 2025, Glenmark Pharmaceuticals share price (NSE: GLENMARK) opened at ₹1,453.90, the same as its previous close of ₹1,453.05. At 11:10 AM, the share price of Glenmark Pharmaceuticals was trading at ₹1,430.80, down by 1.53% …